- Grants since 2016
- 279
- Awarded, last 5 years (where amounts are published)
- —
- Funded works, last 5 years
- 1 976
- Funded works, all time
- 5 201
Grants
2025 · research · PCF Young Investigator Award
Mechanisms of Resistance to PARP Inhibitor in Metastatic Resistant-Castration Prostate Cancer: Triton3 Cohort
Alice Bernard-Tessier · Fondation Gustave Roussy
2025 · research · PCF Young Investigator Award
Dissecting the Significance of Immune Infiltration in Hormone Sensitive Prostate Cancer with Highly-Multiplexed Immunofluorescence
Jeremiah Wala · Dana-Farber Cancer Institute
2025 · research · PCF Young Investigator Award
Developing and Armoring T Cell Receptor Immunotherapy for Prostate Cancer on Multiple High-frequency HLA Alleles
Zhiyuan Mao · University of California, Los Angeles
2025 · research · PCF Challenge Award
AI-driven Omics-Mapping of Key Factors for Long-term Remission in mPCa and Development of Novel Adoptive Cell Immunotherapy
Ping Mu · Yale University
2024 · research · PCF Challenge Award
Characterizing B-Cell Receptor Repertoire to Understand Immunotherapy Response in Prostate Cancer
Lucia Nappi · Vancouver Prostate Centre
2024 · research · PCF Challenge Award
Donors: Anonymous, Bill Ackman and Neri Oxman, Adam Aron (AMC Cares), Greg Brown, William Corry, Jason Safriet, Jack Hidary, Asha Jadeja
Michael Freeman · University of California, Los Angeles
2024 · research · PCF Young Investigator Award
Targeting Metabolic Rewiring to Inhibit Castration-Resistant Prostate Cancer Progression and Bone Metastasis
Estefania Labanca · The University of Texas MD Anderson Cancer Center
2024 · research · PCF Young Investigator Award
Integrating Artificial Intelligence and Genomic Profiling for Personalized Treatment in Oligometastatic Prostate Cancer
Philip Sutera · University of Rochester
2024 · research · PCF Challenge Award
Development and Optimization of CEACAM5-Targeted Imaging and Therapeutics
Scott Tagawa · Memorial Sloan Kettering Cancer Center
2024 · research · PCF Young Investigator Award
A Novel Liquid Biopsy Assay Using Circulating Tumor Extracellular Vesicles to Monitor Prostate Cancer Tumor Evolution and Emergence of Drug Resistance
Irene Casanova-Salas · Vall d'Hebron Institute of Oncology
2024 · research · PCF Young Investigator Award
Artificial Intelligence to Augment MRI-Based Identification of Extraprostatic Extension and Predictive Models for Prostate Cancer
Hiten Patel · Northwestern University
2024 · research · PCF Young Investigator Award
Identifying Prostate Cancers with Lethal Potential in Active Surveillance Candidates Using a Liquid Biomarker and Digital Pathology
Claire De La Calle · University of Washington
2024 · research · PCF Young Investigator Award
Defining the Functional and Spatial Immune Repertoire Roles of the Prostate Tumor Microenvironment
Cara Schafer · Center For Prostate Disease Research
2024 · research · PCF Challenge Award
Isotopic Fingerprinting of Hair to Detect the Presence of Cancer
Kenneth Pienta · Johns Hopkins University
2024 · research · PCF Young Investigator Award
Investigation of a Novel NSD2 Inhibitor KTX-1001 in Targeting Lineage Plasticity and Treatment Resistance in NEPC and mCRPC Subtypes
2024 · research · PCF Young Investigator Award
Interrogating Underexplored Subtypes of Metastatic Castration Resistant Prostate Cancer
Chien-Kuang Cornelia Ding · University of California, San Francisco
2024 · research · PCF Young Investigator Award
Elucidating Drivers of Immune Evasion and Disease Progression in Advanced Prostate Cancer Using Spatial Single-Cell Profiling
William Chen · University of California, San Francisco
2024 · research · PCF Young Investigator Award
Validation and Clinical Qualification of Biomarkers Associated with PC Inflammation That Have Multi-Purpose Clinical Utility
Arian Lundberg · Institute of Cancer Research
2024 · research · PCF Young Investigator Award
Leveraging Multimodal Data to Further Define and Target Oligometastatic Prostate Cancer
Edward Christopher Dee · Memorial Sloan Kettering Cancer Center
2024 · research · PCF Challenge Award
Temporal Charting of Treatment-Related Lethal Prostate Cancer Lesions Using Liquid Biopsies and Multi-Region Tumor Sequencing: Development, Testing, and Validation of a Computational Framework Within the PCF SELECT, PRIME, and PEACE Consortia
Francesca Demichelis · University of Trento
2024 · research · PCF Young Investigator Award
Dissecting Myeloid-Mediated Mechanisms of Immunotherapy Resistance in Advanced Prostate Cancer at Single-Cell Resolution
Aram Lyu · Fred Hutch Cancer Center
2024 · research · PCF Young Investigator Award
Anatomical and Cellular Determinants of Intrinsic and Acquired Resistance to PSMA-Targeted Therapy
Martin Bakht · Harvard: Dana-farber Cancer Institute
2024 · research · PCF Challenge Award
Donors: Anonymous, Patrice and Precious Motsepe (Motsepe Foundation), Stephen and Christine Schwarzman, Leerom and Karolina Segal, Cindy and Rob Citrone (Citrone 33), David and Kristin Steinberg
Stacy Loeb · Brigham and Women's Hospital
2024 · research · PCF Challenge Award
Multicolor PET Imaging to Interrogate Prostate Cancer Biology
Jan Grimm · Memorial Sloan Kettering Cancer Center
2024 · research · PCF Young Investigator Award
Investigating the Potential of Repurposing Anti-Diabetic/Obesity Drugs for the Treatment of Obesity-Driven Aggressive Prostate Cancer
Nil Grunberg · Imperial College London
2024 · research · PCF Young Investigator Award
NFI-Family Transcription Factors Support AR-activity During Prostate Cancer Progression
Larysa Poluben · Harvard: Beth Israel Deaconess Medical Center (bidmc)
2024 · research · PCF Young Investigator Award
STEAP1-Targeted Immunotherapy in Prostate Cancer
Carissa Chu · University of California, San Francisco
2024 · research · PCF Young Investigator Award
Eliminating Inequities in Prostate Cancer Genetic Testing Access with an Artificial Intelligence – Assisted Health Coach Model
Daniel Kwon · University of California, San Francisco
2024 · research · PCF Young Investigator Award
Developing Engineered Immune Cell Therapies for Metastatic Castration-Resistant Prostate Cancer to Increase Efficacy and Decrease Toxicity
Nour Shobaki · University of Pennsylvania
2024 · research · PCF Young Investigator Award
Development of Inhibitor Targeting Master Regulator ONECUT2 for Advanced Prostate Cancer
Brad Gallent · Cedars-Sinai Medical Center
2024 · research · PCF Young Investigator Award
Metabolic Targeting of Poor Prognostic Prostate Cancer
Tahlia Scheinberg · Chris O’Brien Lifehouse
2024 · research · PCF Young Investigator Award
Targeting Gene Fusion Derived pMHC Neoantigens in Prostate Cancer
Daniel Rosen · Harvard: Massachusetts General Hospital
2024 · research · PCF Young Investigator Award
Translational Applications of Epigenomic Liquid Biopsy to Advance Prostate Cancer Treatment.
Sylvan Baca · Harvard: Dana-farber Cancer Institute
2024 · research · PCF Challenge Award
Targeting CRPC at the Intersection of Alternative Polyadenylation and Cellular Plasticity
Scott Dehm · University of Minnesota
2024 · research · PCF Challenge Award
Combination of POLQ inhibitor plus PARP inhibitor for HR-deficient and ATM-deficient Prostate Cancer
Alan D’Andrea · Brigham and Women's Hospital
2024 · research · PCF Challenge Award
Germline Genomic and Clinical Predictors of Prostate Cancer Outcomes and Treatment Toxicity in the ProtecT Randomized Trial
Tyler Seibert · University of Bristol
2024 · research · PCF Young Investigator Award
Multilevel Assessment of Social Needs and Partnering With Community Stakeholders to Prospectively Address Local Barriers to Prostate Cancer Care
Samuel Washington · University of California, San Francisco
2024 · research · PCF Challenge Award
Optimizing Patient Selection for PSMA Targeted Radiotherapy Using Individual Lesion Characteristics
Glenn Liu · University of Wisconsin–Madison
2024 · research · PCF Young Investigator Award
Serial Blood-Based Epi-genotyping of Metastatic Castration Resistant Prostate Cancer (mCRPC) to Understand Response and Resistance to Lutetium-177-PSMA-617 (Lu-PSMA) Treatment Strategies
Sofie Tolmeijer · University of British Columbia
2024 · research · PCF Challenge Award
Developing Novel and Transformative Therapeutic Strategies Targeting mRNA translation for the Treatment of Molecularly Defined Prostate Cancer Subtypes
Adam Sharp · Institute of Cancer Research